Overview

Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease

Status:
Terminated
Trial end date:
2020-08-13
Target enrollment:
Participant gender:
Summary
The purpose of the study is to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Collaborators:
IQVIA
Iqvia Pty Ltd
Treatments:
Ticagrelor